Study shows ability of new agent to prevent strokes in patients with atrial fibrillation
Wednesday, August 10, 2011 - 16:30
in Health & Medicine
In the primary result from the largest double-blind study ever completed to assess a drug's effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting drug, was shown to be an attractive alternative to warfarin, the current standard for treatment of atrial fibrillation.